.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Jade Nectar’s sales mix remained overwhelmingly concentrated in Tincture & Sublingual at 99.34% share, with that category up 8.64% month over month but down 43.54% year over year, while Topical rose to 0.66% share on 116.04% MoM and 111.30% YoY growth. Despite the brand’s overall sales decline of 43.27% year over year and a slight 0.68% YoY decrease in average price, the average price within Tincture & Sublingual held at 28.39, and Topical averaged 25.22, suggesting price was steady while volume shifted. The brand ranked 10 in Tincture & Sublingual in California, and its mix, with 99.34% in a single category and only 0.66% in Topical, implies concentration risk even as the small Topical base posts triple‑digit growth.
The combination of an 8.64% MoM lift in Tincture & Sublingual alongside a 116.04% MoM surge in Topical indicates Jade Nectar is getting incremental traction at the edges without yet diversifying meaningfully, and the 10th-place rank in California Tincture & Sublingual points to a crowded mid‑tier position rather than clear category leadership. With Tincture & Sublingual down 43.54% YoY against a brand-level 43.27% YoY decline, the core is pacing the contraction, while Topical’s 111.30% YoY growth at just 0.66% share limits its ability to offset losses. The pattern implies Jade Nectar’s near-term positioning hinges on defending rank in Tincture & Sublingual while selectively scaling Topical to lift mix share by multiple percentage points, using modest price flexibility around the current 28.36 average to prioritize velocity over ticket size.
Competitive Landscape
Jade Nectar sits at rank #10 in CA Tincture & Sublingual for May 2026, slipping 1 position from rank #9 year over year and down 1 spot from rank #9 in February 2026; the brand’s peak at rank #7 in September 2024 marks a 3-place decline from its high point. While Jade Nectar moved down 1 rank YoY, ABX / AbsoluteXtracts improved from #6 to #5, and category leader Papa & Barkley held #1 with a -13.3% YoY sales change versus Jade Nectar’s rank deterioration; in parallel, Yummi Karma remained at #2 while Care By Design stayed at #3 despite a -20.2% YoY sales contraction, indicating stability at the top even as mid-tier positions reshuffle. The pattern implies Jade Nectar’s step-down of 1 rank alongside a 3-rank gap from its September 2024 peak points to share pressure from mid-tier climbers and a need to counter stability at the top three ranks.
Notable Products
Sativa Tincture Drops (1000mg THC, 30ml) posted the steepest move in May 2026 with a -55.1% month-over-month decline and slid to rank 7, while Indica High Potency Tincture (1000mg THC, 30ml) surged 156.4% MoM to rank 4. The category remained concentrated as all top 10 SKUs were Tincture & Sublingual, with leadership anchored by CBD/THC 30:1 CBD Drops (900mg CBD, 30mg THC, 30ml) at rank 1 and a 35.4% MoM gain. This divergence between a falling Sativa flagship and a rising Indica high-potency SKU implies Jade Nectar is pivoting toward higher-THC and effect-specific formulations even as CBD-forward leaders sustain the brand’s rank ceiling.
Indica Sativa High Potency Blend Tincture (1000mg THC, 30ml) climbed 38.4% MoM to rank 2, while Indica Tincture (450mg) dropped 20.8% MoM at rank 3, and CBD:THC 1:1 Balanced Drops (150mg CBD, 150mg THC, 1oz) advanced 49.6% MoM at rank 6 on $5,916 in sales. With three SKUs moving more than ±20% MoM inside the top 6 and two ranking in the top 2, the mix indicates upside concentrating in high-potency and balanced-dose formats, signaling a shift from legacy mid-potency Indica toward formulations tied to stronger or more targeted effects.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
